Topics

Diseases and Illnesses
Experimental Ebola medication ZMapp saves infected monkeys
Experimental Ebola medication ZMapp saves infected monkeys

In speedy testing conducted as West Africa's Ebola epidemic began to mushroom, researchers have found that ZMapp, the experimental drug that has been used in seven infected human patients to date, prompted the recovery of 18 macaque monkeys infected with the virus. Even when treatment with ZMapp was initiated five days after infection -- a point at which researchers describe the sick monkeys as being "three days away from death" -- the experimental biologic therapy reversed the bleeding, rashes and elevated liver enzymes that are Ebola's hallmark symptoms, and drove the virus to insignificant levels. Three infected macaques that did not get ZMapp were dead within...

Loading